M. Giossi

Comparative analysis of isolated human bronchi contraction and biosynthesis of cysteinyl leukotrienes using a direct 5-lipoxygenase inhibitor.

A. Sala, M. Civelli, G. Folco, 1997, Biochemical pharmacology.

CHF 2206, a new potent vasodilating and antiaggregating drug as potential nitric oxide donor.

M. Civelli, P. Caruso, M. Giossi, 1994, European journal of pharmacology.

Selective medicated (normal saline and exogenous surfactant) bronchoalveolar lavage in severe aspiration syndrome in children*

M. Luchetti, G. Marraro, C. Spada, 2007, Pediatric critical care medicine : a journal of the Society of Critical Care Medicine and the World Federation of Pediatric Intensive and Critical Care Societies.

Inhibition of parathyroid hormone-stimulated resorption in cultured fetal rat long bones by the main metabolites of ipriflavone

M. Civelli, P. Caruso, M. Giossi, 1996, Calcified Tissue International.

Modulation of arachidonic acid metabolism by orally administered morniflumate in man

M. Civelli, G. Folco, T. Viganó, 1991, Agents and Actions.

Bilirubin influence on oxidative lung damage and surfactant surface tension properties

A. Di Filippo, G. Buonocore, M. Tronchin, 2004, Pediatric pulmonology.

The involvement of the release of nitric oxide in the pharmacological activity of the new furoxan derivative CHF 2363

M. Civelli, P. Caruso, M. Giossi, 1996, British journal of pharmacology.

Novel Basic Isoflavones as Inhibitors of Bone Resorption

P. Carrupt, B. Testa, E. Galbiati, 2001 .